NCT02778880View on ClinicalTrials.gov

Pain Reduction With Intranasal Medications for Extremity Injuries

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 22, 2017

Study Completion Date

March 21, 2017

Conditions
PainTraumatic Limb Injury
Interventions
DRUG

Ketamine

DRUG

Fentanyl

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02778880 - Pain Reduction With Intranasal Medications for Extremity Injuries | Biotech Hunter | Biotech Hunter